OrthogenRx Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 29

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 8

OrthogenRx General Information

Description

Developer of knee joint pain injection designed for the treatment of musculoskeletal conditions. The company's products lubricate the joint and relieve mild to moderate knee pain for patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, enabling patients to have access to safe and non-surgical alternatives.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Doylestown Commerce Center
  • 2005 South Easton Road, Suite 207
  • Doylestown, PA 18901
  • United States
+1 (215)
Primary Industry
Other Devices and Supplies
Other Industries
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • Doylestown Commerce Center
  • 2005 South Easton Road, Suite 207
  • Doylestown, PA 18901
  • United States
+1 (215)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OrthogenRx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OrthogenRx‘s full profile, request access.

Request a free trial

OrthogenRx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of knee joint pain injection designed for the treatment of musculoskeletal conditions. The company's products
Other Devices and Supplies
Doylestown, PA
29 As of 2022

Edina, MN
 

Bedford, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OrthogenRx Competitors (6)

One of OrthogenRx’s 6 competitors is Relievant, a Formerly VC-backed company based in Edina, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Relievant Formerly VC-backed Edina, MN
Anika Therapeutics Formerly VC-backed Bedford, MA
Bioventus Formerly PE-Backed Durham, NC
Ferring Pharmaceuticals Private Equity-Backed Saint-Prex, Switzerland
Seikagaku Corporation Tokyo, Japan
To view OrthogenRx’s complete competitors history, request access »

OrthogenRx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OrthogenRx Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore OrthogenRx‘s full profile, request access.

Request a free trial

OrthogenRx FAQs

  • When was OrthogenRx founded?

    OrthogenRx was founded in 2013.

  • Where is OrthogenRx headquartered?

    OrthogenRx is headquartered in Doylestown, PA.

  • What is the size of OrthogenRx?

    OrthogenRx has 29 total employees.

  • What industry is OrthogenRx in?

    OrthogenRx’s primary industry is Other Devices and Supplies.

  • Is OrthogenRx a private or public company?

    OrthogenRx is a Private company.

  • What is the current valuation of OrthogenRx?

    The current valuation of OrthogenRx is .

  • What is OrthogenRx’s current revenue?

    The current revenue for OrthogenRx is .

  • How much funding has OrthogenRx raised over time?

    OrthogenRx has raised $10.5M.

  • Who are OrthogenRx’s investors?

    Ben Franklin Technology Partners of Southeastern Pennsylvania and New Age Ventures have invested in OrthogenRx.

  • Who are OrthogenRx’s competitors?

    Relievant, Anika Therapeutics, Bioventus, Ferring Pharmaceuticals, and Seikagaku are some of the 6 competitors of OrthogenRx.

  • When was OrthogenRx acquired?

    OrthogenRx was acquired on 20-Jan-2022.

  • Who acquired OrthogenRx?

    OrthogenRx was acquired by Avanos Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »